EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
31 hedge funds and large institutions have $185M invested in ESSA Pharma in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$245K
Puts
$20K
Top Buyers
| 1 | +$3.27M | |
| 2 | +$181K | |
| 3 | +$54.2K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$29.1K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$10.5K |
Top Sellers
| 1 | -$872K | |
| 2 | -$559K | |
| 3 | -$556K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$278K |
| 5 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$137K |